Search

Your search keyword '"Doz F"' showing total 757 results

Search Constraints

Start Over You searched for: Author "Doz F" Remove constraint Author: "Doz F"
757 results on '"Doz F"'

Search Results

1. Retinoblastoma: From genes to patient care

2. Retinoblastoma

3. Guidelines, “minimal requirements” and standard of care in glioblastoma around the Mediterranean Area: A report from the AROME (Association of Radiotherapy and Oncology of the Mediterranean arEa) Neuro-Oncology working party

10. 463P Efficacy and safety of larotrectinib in a pooled analysis of patients (Pts) with tropomyosin receptor kinase (TRK) fusion cancer with an extended follow-up

11. 464P Intra-patient (Pt) comparison from larotrectinib (Laro) clinical trials in tropomyosin receptor kinase (TRK) fusion cancer: An expanded dataset

12. Retinoblastoma

14. Clinical characteristics and clinical evolution of a large cohort of pediatric patients with primary central nervous system (cns) tumors and tropomyosin receptor kinase (trk) fusion.

15. Efficacy and safety of larotrectinib in TRK fusion-positive primary central nervous system tumors.

16. IMMU-08. Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: efficacy, safety, biomarker, and pharmacokinetic results from Checkmate 908

17. HGG-11. Clinical characteristics and clinical evolution of a large cohort of pediatric patients with primary central nervous system (CNS) tumors and tropomyosin receptor kinase (TRK) fusion.

19. Hippocampal Sparing Radiotherapy in adults with Primary Brain Tumors: A comparative planning and dosimetric study using IMPT, IMRT and 3DCRT

20. Les médulloblastomes : revue générale

21. Imaging Features with Histopathologic Correlation of CNS High-Grade Neuroepithelial Tumors with a BCOR Internal Tandem Duplication

22. Current Indications of Secondary Enucleation in Retinoblastoma Management: A Position Paper on Behalf of the European Retinoblastoma Group (EURbG)

23. 534P Larotrectinib in non-CNS TRK fusion cancer patients: Outcomes by prior therapy and performance status

25. RARE-07. EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION-POSITIVE PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS

29. Parental comprehension and satisfaction in informed consent in paediatric clinical trials: a prospective study on childhood leukaemia

31. Malformations, Genetic Abnormalities, and Wilms Tumor

34. Le rétinoblastome

35. Phase II results from a phase I/II study to assess the safety and efficacy of weekly nab-paclitaxel in paediatric patients with recurrent or refractory solid tumours: A collaboration with the European Innovative Therapies for Children with Cancer Network

36. Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure

40. Parental consent in paediatric clinical research

47. 1955P Survival benefits of larotrectinib in an integrated dataset of patients with TRK fusion cancer

48. Focal Areas of High Signal Intensity in Children with Neurofibromatosis Type 1: Expected Evolution on MRI

Catalog

Books, media, physical & digital resources